(Date:11/20/2008)...ewswire/ -- Precyse Solutions, the leader in,driv...rmance through,technology and management solution...il of Pennsylvania as "Technology Company of the Y...e Kimmel Center. The Annual Gala honors the,regi...d entrepreneurs. More,than 1200 business leaders...
(Date:11/20/2008)...g Alzheimer,s relatives at risk for hospital visit...althDay News) -- The stress of providing care for ... of family caregivers having at least one emergenc... Indiana University study. , It,s long been re...t is difficult, but the Indiana University researc...
(Date:11/20/2008)...er Tips for Finding Quality Care , ARLINGTON HE...nsumers looking to cut costs during the economic d... care, warns the American Society of Plastic Surge...bstitute fillers for facelifts, ASPS says the wors...fessional training. This concern was discussed rec...
(Date:11/20/2008)...uctant to undergo a routine but painful colonoscop...ording to the American Cancer Society, colon cance...n men and women and kills about 50,000 Americans e...cer have no symptoms or family history," says Prof...nterology, at Tel Aviv University,s Sackler Facult...
Breaking Medicine News(10 mins):Health News:Precyse Solutions Honored as 'Technology Company of the Year' 2Health News:When the Caregiver Becomes the Patient 2Health News:Caution Urged as Patients Seek Deals on Cosmetic Surgery 2Health News:A simple blood test for colon cancer 2... going full steam to counter skin diseases that a... the spread of tinea(fungal infections),scabies an...ong infants living in the ,far flung interior abor...ely and effective treatment for the same. Povert...
... Awareness Month and with that comes the shocking ...e campaign for raising funds towards breast cancer...s, cosmetics and teddy bears, as well as major cha...ganza "Boobie-Thon 2006". The Boobie-Thon that ha...
...drug that could treat blindness by combating the w...r degeneration (AMD). AMD usually affects people a...uickly and can cause blindness. The drug called L...ents in the US who received monthly injections of ...
...sical exercise for their future good health, says ...w University studied 545 children at 36 nurseries ...n who had the recommended adult level of exercise ...a week, reported the online edition of BBC News. ...
Other Medicine News:Health News:All in the Name of ‘Breast Cancer Awareness 2(Date:11/20/2008)...RELIMINARY TOP LINE RESULTS OF FIRST PHASE III TRI...TIGUE, AND IMPROVEMENT IN DAILY FUNCTION, IN, ... PALO ALTO, Calif., and BRUSSELS, Belgium, Nov. ..., Inc. (Nasdaq: JAZZ ) and UCB (Euronext Brussel...line results from the first of two,Phase III pivo...
(Date:11/20/2008)...LLA, Calif., Nov. 20 Dus..., announced today that it has submitted its,pivot...ew under a Special,Protocol Assessment (SPA) proc...(FDA). , Subject to securing an agreement w...prospective, double-blind, placebo-controlled and ...
(Date:11/20/2008)...ROMSO, Norway, November 20 The Sca...opharma has announced results of studies on its,l...ICAAC in Washington, DC,the studies showed that ...,bacteriocidal effect, significantly better toward... pyogenes than marketed gold standard drugs. In,a...
(Date:11/19/2008)...ude scientists report basic findings on critical e...ow to better treat an array of disorders , , ...-- Scientists at St. Jude Children,s Research Hos...one of the body,s enzyme workhorses called calpain...rs, calpains function in many cellular processes, ...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Yes no maybe so 3A New model helps identify what works in mental health treatment 12047 1U M scientists develop tool to probe role of oxidative stress in aging disease 12045 1Chronic pain should be considered a disease 12043 1Chronic pain should be considered a disease 12043 2Abbott Announces 10 8 Percent Increase in Quarterly Dividend 12041 1...Y, April 30, 2007-Australian bio-discovery company...iminary trials of its,patented needle-free vaccine...ermally (through the skin) without the need for an... the research points the way,to the possibility th... , "With the winter months fast approaching, peopl...
...OWN, N.Y.--(BUSINESS WIRE)--May 1, 2007 - Progenic...nced positive,results from the first clinical tria...uals infected with the human immunodeficiency,viru...eiving a,single 5.0 mg/kg dose of PRO 140 achieved...ns in the blood of 98.5% (1.83,log10), with indivi...
Other Medicine Technology:Apollo develops needle-free topical vaccine 2Apollo develops needle-free topical vaccine 3Apollo develops needle-free topical vaccine 4Apollo develops needle-free topical vaccine 5Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 2Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 3Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 4Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 5Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 6Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 7SonoVue, a new Contrast Agent for Ultrasonography is an aqueous suspension of stabilized SF6 microbubbles. The size of these microbubbles is between 1 and 10 m, and their number is between 2 and 5 x
ULTRAVIST (iopromide) injection is a nonionic, iodinated, low-osmolar radiological contrast agent for intravascular administration. Introduced in the U.S. in 1995, ten years after becoming available
The Pinn-ACL Femoral Guide is offered in right and left versions and is designed to easily accommodate unusually large or small knees.
Hand surgery basic instrument set
Medicine Products: